Offering was conducted by bookrunners Credit Suisse and William Blair
By Devika Patel
Knoxville, Tenn., April 6 – Assembly Biosciences Inc. said the underwriters for its initial public offering of stock opted to exercise the deal’s $11.25 million greenshoe in full for total proceeds of $86.25 million. The offering was announced on March 18 and priced for $75 million with the greenshoe on March 19.
The company sold 6,388,888 common shares at $13.50 per share. The price per share reflects a 2.67% discount to the March 18 closing share price of $13.87. Of the shares, 833,333 were part of the fully exercised greenshoe.
Credit Suisse and William Blair were the joint lead bookrunning managers.
The specialty pharmaceutical company is based in New York.
| Issuer: | Assembly Biosciences Inc.
|
| Issue: | Common stock
|
| Amount: | $86,249,988 (including $11,249,996 greenshoe)
|
| Shares: | 6,388,888
|
| Price: | $13.50
|
| Warrants: | No
|
| Bookrunners: | Credit Suisse and William Blair
|
| Announcement date: | March 18
|
| Pricing date: | March 19
|
| Settlement date: | April 6
|
| Stock symbol: | Nasdaq: ASMB
|
| Stock price: | $13.87 at close March 18
|
| Market capitalization: | $147.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
